Bluejay Diagnostics, Inc. (BJDX)
Largest Insider Buys in Sector
BJDX Stock Price History Chart
BJDX Stock Performance
About Bluejay Diagnostics, Inc.
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Insider Activity of Bluejay Diagnostics, Inc.
Over the last 12 months, insiders at Bluejay Diagnostics, Inc. have bought $0 and sold $0 worth of Bluejay Diagnostics, Inc. stock.
On average, over the past 5 years, insiders at Bluejay Diagnostics, Inc. have bought $92,359 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 500 shares for transaction amount of $1,635 was made by Dey Indranil (President and CEO) on 2023‑12‑13.
List of Insider Buy and Sell Transactions, Bluejay Diagnostics, Inc.
| 2023-12-13 | President and CEO | 500 0.044% | $3.27 | $1,635 | -85.64% | |||
| 2023-12-13 | director | 500 0.0413% | $3.07 | $1,535 | -85.64% | |||
| 2023-03-28 | President and CEO | 2,000 0.0105% | $0.44 | $880 | -49.65% | |||
| 2023-03-27 | President and CEO | 8,000 0.0393% | $0.44 | $3,520 | -53.01% | |||
| 2023-03-24 | director | 10,000 0.0502% | $0.44 | $4,400 | -51.67% | |||
| 2022-08-26 | Chief Financial Officer | 20,000 0.0992% | $1.03 | $20,600 | -57.23% | |||
| 2022-04-25 | Chief Financial Officer | 20,000 0.0943% | $0.99 | $19,800 | -21.74% | |||
| 2022-03-17 | 40,000 0.1983% | $1.18 | $47,120 | -24.35% | ||||
| 2022-03-17 | Chief Financial Officer | 2,500 0.0122% | $1.16 | $2,898 | -24.35% | |||
| 2022-03-17 | 10,000 0.0498% | $1.18 | $11,830 | -24.35% | ||||
| 2022-03-16 | 60,000 0.2823% | $1.09 | $65,400 | -20.91% | ||||
| 2022-03-14 | Chief Financial Officer | 5,000 0.0274% | $1.02 | $5,100 | +1.69% |